NEW YORK, March 12, 2020 /PRNewswire/ — RemoteDesk by Verificient announces that in response to the recent coronavirus outbreak, RemoteDesk will be offering 10,000 (ten thousand) free licenses through the summer of 2020 to qualified businesses.
The coronavirus has taken many organizations, businesses, educational institutions, and governments by surprise and these groups are recommending that people work from home to help reduce the spread of the virus. However, the shift from working from the office to working from home presents many challenges: maintaining high productivity, preserving data security, and compliance.
Rahul Siddharth, COO, Verificient Technologies, Inc, “Remote workforce management needs to be the foundation of every organization’s emergency preparedness plan or disaster recovery plan. RemoteDesk can secure teleworkers’ home office workstations and ensure continued productivity during this sudden short term coronavirus pandemic. RemoteDesk can provide full transparency, mitigate the compliance and security risks of remote agents and help solve organizations’ critical needs in adopting a long term remote workforce.”
About RemoteDesk
RemoteDesk is the world’s most advanced AI-based remote workforce management solution for work-at-home compliance and security. RemoteDesk’s elegant and simple AI technology securely monitors teleworkers while providing clear transparency, accountability, work-at-home policy compliance, and risk management for outsourcing initiatives. RemoteDesk is powered by Verificient Technologies, Inc., which specializes in continuous identity verification through the use of its patented AI.
View original content to download multimedia:http://www.prnewswire.com/news-releases/remotedesk-offers-10-000-free-licenses-through-summer-2020-for-businesses-affected-by-coronavirus-301022150.html
SOURCE RemoteDesk
Amazfit Active becomes the world's first smartwatch under €200 to fully-integrate AI. MILPITAS, Calif., July…
Investment will support investigation of Mission's small molecule drug MTX325 in patients with early-stage Parkinson's…
New report highlights challenges and opportunities in resilient MedTech industry LONDON, July 2, 2024 /PRNewswire/…
Data presented at the 2024 FMF (Fetal Medicine Foundation) World Congress in Lisbon, Portugal shows the…
Change of Registered AddressLONDON, UK / ACCESSWIRE / July 2, 2024 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), ('Poolbeg'…
GOTHENBURG, SWEDEN / ACCESSWIRE / July 2, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, July…